| Dr Scott Houser, MD | |
|
590 Naamans Rd, Claymont, DE 19703-2308 | |
| (302) 757-3221 | |
| (302) 385-2080 |
| Full Name | Dr Scott Houser |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 590 Naamans Rd, Claymont, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093844771 | NPI | - | NPPES |
| 1000030589 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | C10005726 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coras Wellness And Behavioral Health Llc | 1456741248 | 15 |
| Phc Meadowwood, Llc | 9335318823 | 3 |
News Archive
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today praised Senate leadership for their tireless work on historic health care reform, and encouraged lawmakers to continue their steadfast work on this important issue in the weeks to come.
› Verified 1 days ago
| Entity Name | Connections Community Support Programs Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689733792 PECOS PAC ID: 0042290686 Enrollment ID: O20040723000144 |
News Archive
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today praised Senate leadership for their tireless work on historic health care reform, and encouraged lawmakers to continue their steadfast work on this important issue in the weeks to come.
› Verified 1 days ago
| Entity Name | Phc Meadowwood, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528357357 PECOS PAC ID: 9335318823 Enrollment ID: O20110927000062 |
News Archive
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today praised Senate leadership for their tireless work on historic health care reform, and encouraged lawmakers to continue their steadfast work on this important issue in the weeks to come.
› Verified 1 days ago
| Entity Name | Coras Wellness And Behavioral Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023686284 PECOS PAC ID: 1456741248 Enrollment ID: O20211210000182 |
News Archive
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today praised Senate leadership for their tireless work on historic health care reform, and encouraged lawmakers to continue their steadfast work on this important issue in the weeks to come.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Houser, MD 590 Naamans Rd, Claymont, DE 19703-2308 Ph: (302) 757-3221 | Dr Scott Houser, MD 590 Naamans Rd, Claymont, DE 19703-2308 Ph: (302) 757-3221 |
News Archive
National Health Investors, Inc. announced today a $15.3 million acquisition of The Inn at Halcyon Village in Marysville, Ohio.
Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today praised Senate leadership for their tireless work on historic health care reform, and encouraged lawmakers to continue their steadfast work on this important issue in the weeks to come.
› Verified 1 days ago
Dr. Phyllis Margaret Smoyer, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3301 Green St, Claymont Community Center Counseling, Claymont, DE 19703 Phone: 302-792-2757 | |
Dr. Noam U Epstein, MD, MS Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1012 Lighthorse Ln, Claymont, DE 19703 Phone: 773-939-6858 |